Our position on the leading issues affecting research and people with dementia and how these issues impact our work.
Dementia treatments: what matters most to people
Our position on the outcomes from new treatments that are important to people and the side-effects they might be willing to risk.
Major Conditions Strategy
Alzheimer’s Research UK responds to the government’s call for evidence on the Major Conditions Strategy
Working with pharmaceutical industry
Detailing the policies that govern our work with pharmaceutical and biotech companies.